Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMed

[Therapeutic Effect of SPK1 Gene Transfected Adipose Derived Mesenchymal Stem Cells on Experimental Autoimmune Encephalomyelitis Mice and Its Effect on T Helper Cell 17/Regulatory T Cells Balance].

Zhou T., Xu CP., Xiao Y., Zhang Q., Li L.

Animal Study on Neuroinflammation, Autoimmune Research, published in Zhongguo Yi Xue Ke Xue Yuan Xue Bao (2020) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Zhongguo Yi Xue Ke Xue Yuan Xue Bao (2020)
Country
China
Reported sample size
—
Source database
PubMed
PMID
33423722
DOI
10.3881/j.issn.1000-503X.11888
Citations
1

Abstract (original English)

Objective To investigate the therapeutic effect of SPK1 gene transfected adipose derived mesenchymal stem cells(ADMSC)on experimental autoimmune encephalomyelitis mice and the effect on T helper cell 17(Th17)/regulatory T(Treg) cells balance. Methods EAE was induced by myelin oligodendrocyte glycoprotein 35-55 in mice.Totally 44 mice were randomly divided into four groups:normal control group(NC group),model group(EAE group),ADMSC group,and ADMSC-SPK1 group.Forty days after injection,the pathological changes of brain and spinal cord,Th17/Treg-related inflammatory markers in brain tissue,expressions of interleukin-17A(IL-17A)and forkhead box protein p3(Foxp3)in brain and spinal cord tissue,and flow cytometric results of spleen immune cells were detected. Results Forty days after the injection,serious inflammatory cell infiltration and demyelination occurred in the brain and spinal cord of EAE group,whereas demyelination and axonal injury were improved in ADMSC group and ADMSC-SPK1 group.Compared with EAE group,the ADMSC group and ADMSC-SPK1 group had significantly improved levels of IL-17A( Z =1.021, P =0.017; Z =1.193, P =0.009)and tumor necrosis factor-α(TNF-α)( Z =2.540, P =0.004; Z =3.005, P =0.006).The expression level of IL-17A in mouse brain and spinal cord tissues was significantly reduced in the ADMSC group( t =10.323, P =0.013; t =7.422, P =0.008),and it was significan

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Adipose TissueAnimalsCytokinesEncephalomyelitis, Autoimmune, ExperimentalInterleukin-17Mesenchymal Stem Cell TransplantationMesenchymal Stem CellsMiceMice, Inbred C57BLPhosphotransferases (Alcohol Group Acceptor)

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research